Literature DB >> 6254343

Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy.

B O Olofsson, R Andersson, B Furberg.   

Abstract

Atrioventricular and/or intraventricular conduction disturbances were found in 48 (67%) out of 71 patients with familial amyloidosis with polyneuropathy. Low voltage, often described in various forms of heart amyloidosis, was seen in one patient only. Myocardial infarction patterns, also often reported in heart amyloidosis, were not present in our patients. The prevalence of conduction disturbances increased with the duration of the disease. In 28 out of 47 patients from whom more than one ECG recording was available, a progression of conduction disturbances could be seen. Ten patients developed high-degree conduction disturbances and required permanent pacemaker treatment.

Entities:  

Mesh:

Year:  1980        PMID: 6254343     DOI: 10.1111/j.0954-6820.1980.tb01155.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  5 in total

1.  Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

Authors:  S W Dubrey; K Cha; M Skinner; M LaValley; R H Falk
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

2.  The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden.

Authors:  A Eriksson; P Eriksson; B O Olofsson; L E Thornell
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

3.  Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy.

Authors:  P Eriksson; K Karp; P Bjerle; B O Olofsson
Journal:  Br Heart J       Date:  1984-06

Review 4.  [Autonomic disorders in polyneuropathies].

Authors:  M J Hilz; M Dütsch; B Neundörfer
Journal:  Med Klin (Munich)       Date:  1998-09-15

5.  Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.

Authors:  P Eriksson; C Backman; P Bjerle; A Eriksson; S Holm; B O Olofsson
Journal:  Br Heart J       Date:  1984-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.